Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nagashima, M.
Right arrow Articles by Yoshino, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagashima, M.
Right arrow Articles by Yoshino, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 1255-1262
© 2000 British Society for Rheumatology

Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis

M. Nagashima, K. Wauke, D. Hirano, S. Ishigami, H. Aono1, M. Takai1, M. Sasano1 and S. Yoshino

Department of Joint Disease and Rheumatism, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8603 and
1 Developmental Research Division, Santen Pharmaceutical Co., Ltd, 3-9-19, Shimoshinjo, Higashiyodogawa, Osaka 533-8651, Japan

Objective. To examine whether different combinations of disease-modifying anti-rheumatic drugs (DMARDs), including bucillamine (BUC), gold sodium thiomalate (GST), methotrexate (MTX), salazosulphapyridine (SASP) and dexamethasone (DEX; a steroid), act by inhibiting the production of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in cultured synoviocytes, causing a decrease in their serum concentrations in patients with rheumatoid arthritis (RA).

Methods. The VEGF and bFGF concentrations in cultured synoviocytes and peripheral blood from patients with RA were measured by enzyme-linked immunosorbent assay and their serum concentrations were measured at two time points.

Results. BUC and GST inhibited VEGF production even when given alone, and a combination of BUC, GST and MTX with DEX also inhibited VEGF production. None of the DMARDs or DEX inhibited bFGF production when given alone, but a combination of SASP and GST inhibited the production of bFGF in cultured synoviocytes. Serum VEGF concentrations were significantly decreased 6 months after the commencement of medication compared with their concentrations before medication.

Conclusion Our results show that the effects of a combination of DEX with any two of BUC, GST, SASP and MTX on the production of VEGF and bFGF in cultured synoviocytes and on the serum concentrations of VEGF in patients with RA may be based on synergistic or additive effects of the drugs.

KEY WORDS: Rheumatoid arthritis, Vascular endothelial growth factor, Basic fibroblast growth factor, Disease-modifying anti-rheumatic drugs.

Correspondence to: M. Nagashima, Department of Joint Disease and Rheumatism, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113–8603, Japan.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
P. C. Taylor
Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy
Rheumatology, June 1, 2005; 44(6): 721 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. G. Bernier, D. D. Lazarus, E. Clark, B. Doyle, M. T. Labenski, C. D. Thompson, W. F. Westlin, and G. Hannig
A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis
PNAS, July 20, 2004; 101(29): 10768 - 10773.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Gardner and M. E. Olah
Distinct Protein Kinase C Isoforms Mediate Regulation of Vascular Endothelial Growth Factor Expression by A2A Adenosine Receptor Activation and Phorbol Esters in Pheochromocytoma PC12 Cells
J. Biol. Chem., April 18, 2003; 278(17): 15421 - 15428.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Yanagi, Y. Tamaki, R. Obata, K. Muranaka, N. Homma, H. Matsuoka, and H. Mano
Subconjunctival Administration of Bucillamine Suppresses Choroidal Neovascularization in Rat
Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3495 - 3499.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
P. A. Klimiuk, S. Sierakowski, R. Latosiewicz, B. Cylwik, J. Skowronski, and J. Chwiecko
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis
Rheumatology, January 1, 2002; 41(1): 78 - 87.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.